Research Article

Prognostic Value of Endothelial Progenitor Cells in Acute Myocardial Infarction Patients

Table 1

Comparison of study variables among EPCs (CD34+/CD133+cells) quartiles (M (Q25 and Q75) or M ± SD).

Q1 N = 23 (0–0.288%)Q2 N = 23 (0.288%–0.425%)Q3 N = 23 (0.430%–0.555%)Q4 N = 22 (>0.555%)t/F/x2P

Male (n (%))17 (73.9)16 (69.6)18 (78.3)18 (81.8)1.040.79
Age (years)70.3 ± 11.767.3 ± 14.464.7 ± 15.260.9 ± 17.21.670.17
BMI (kg/m2)22.5 ± 2.422.3 ± 2.522.1 ± 2.121.9 ± 2.40.340.80
APACHEⅡscore (points)25.8 ± 7.918.2 ± 6.814.7 ± 3.815.8 ± 5.614.670.00
STEMI (n (%))17 (73.9)15 (65.2)19 (82.6)18 (86.4)3.420.33
cTnI (μg/L)66.8 (42.4, 85.2)48.5 (38.6, 76.6)48.5 (37.1, 79.3)43.5 (32.8, 75.5)2.760.43
NT-proBNP (ng/L)9920.9 (6483.4, 19339.0)9999.4 (8659.3, 14098.3)8882.9 (7208.2, 13822.9)7824.7 (5870.9, 13802.9)2.330.51
VIS (points)15.7 ± 3.015.0 ± 3.114.9 ± 2.615.3 ± 3.30.300.82
GAP (mm Hg)6.1 ± 1.45.5 ± 1.05.3 ± 0.75.4 ± 0.72.950.04
HCY (μmol/L)29.4 (19.2, 58.6)17.9 (11.9, 30.8)21.6 (15.9, 37.4)16.4 (10.2, 29.5)10.70.01
Creatinine (μmol/L)95.8 (83.3, 119.2)69.5 (60.5, 85.2)88.6 (65.4, 98.3)73.8 (59.7, 98.6)11.090.01
C-reactive protein (mg/L)43.4 (20.3, 60.0)21.2 (4.9, 44.5)13.9 (7.5, 36.6)17.4 (8.6, 43.7)8.190.04
HbAlc (%)6.6 ± 2.05.9 ± 1.56.3 ± 1.85.2 ± 0.82.990.04
CI (L/min/m2)2.2 ± 0.82.8 ± 0.72.6 ± 0.72.3 ± 0.54.190.01
Killip classifications (n (%))5.740.12
 Level I–II3 (13.0)10 (43.5)9 (39.1)7 (31.8)
 Level III–IV20 (87.0)13 (56.5)14 (60.9)15 (68.2)
AB (n (%))2.490.01
 Three territories7 (30.4)5 (21.7)3 (13.0)2 (9.1)
 Two territories8 (30.8)5 (21.7)1 (4.3)5 (22.7)
 One territory8 (30.8)13 (56.5)19 (82.6)15 (68.2)

AMI, indicates acute myocardial infarction; BMI, body mass index; STEMI, ST-elevation MI; VIS, vasoactive inotropic score; GAP, central venous-arterial carbon dioxide difference; HCY, homocysteine; CI, cardiac index; AB, atherosclerotic burden.